Tevogen Bio Holdings (TVGN) Preferred Shares (2024 - 2026)

Tevogen Bio Holdings has reported Preferred Shares for 3 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Preferred Shares changed 0.0% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (changed 0.0% YoY), and the FY2025 full-year result was $6.0 million, up 114.29% from the prior year.
• Preferred Shares for Q1 2026 stood at $2.8 million, down from $6.0 million in the prior quarter.
• The five-year high for Preferred Shares was $6.0 million in Q4 2025, with the low at $2.8 million in Q2 2024.
• Historically, Preferred Shares has averaged $3.4 million across 3 years, with a median of $2.8 million in 2024.
• The largest YoY upside for Preferred Shares was 114.29% in 2025 against a maximum downside of 30.0% in 2025.
• Tevogen Bio Holdings' Preferred Shares stood at $2.8 million in 2024, then surged by 114.29% to $6.0 million in 2025, then sank by 53.33% to $2.8 million in 2026.
• The last three Preferred Shares figures came in at $2.8 million (Q1 2026), $6.0 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.